By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Corvus Pharmaceuticals 

863 Mitten Road, Suite 102

Burlingame  California    U.S.A.
Phone: 650-900-4520 Fax: n/a


SEARCH JOBS








Key Statistics


Email:
Ownership: Private

Web Site: Corvus Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Start Up





Company News
Corvus Pharma Announces Preliminary Phase 1/1b Clinical Data With Lead Checkpoint Inhibitor CPI-444 Demonstrating Safety And Evidence Of Anti-Tumor Activity As A Single Agent In Patients With Advanced Refractory Cancers 11/11/2016 9:04:42 AM
Corvus Pharma Announces Third Quarter Financial Results and Provides Business Update 11/4/2016 9:54:24 AM
Corvus Pharma Announces Biomarker Findings From Phase I/IIb Study Of Lead Oral Checkpoint Inhibitor CPI-444 Presented At ESMO 2016 Congress 10/10/2016 8:49:40 AM
Corvus Pharma To Present Data On Lead Oral Checkpoint Inhibitor CPI-444 At ESMO 2016 Congress 10/4/2016 7:56:17 AM
Corvus Pharma Announces Preclinical And Preliminary Clinical Biomarker Data Of Lead Oral Checkpoint Inhibitor CPI-444 Presented At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/26/2016 7:56:17 AM
Corvus PharmaTo Present Data On Lead Oral Checkpoint Inhibitor CPI-444 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 9/19/2016 8:40:15 AM
Corvus Pharma Announces Second Quarter Financial Results And Provides Business Update 8/5/2016 10:41:10 AM
Corvus Pharma To Present At Cantor Fitzgerald’s Second Annual Healthcare Conference On July 12 7/6/2016 7:58:07 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
Vernalis PLC (VNLPY.PK) Announces Corvus Pharma As Its Worldwide Licensee For Their Adenosine Antagonist Program 1/6/2016 9:39:50 AM
12
//-->